Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v6-FR
Language English French
Date Updated 2021-09-21 2021-08-19
Drug Identification Number 02352583 02352583
Brand name APO-RILUZOLE APO-RILUZOLE
Common or Proper name RILUZOLE RILUZOLE
Company Name APOTEX INC APOTEX INC
Ingredients RILUZOLE RILUZOLE
Strength(s) 50MG 50MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 60 BTL 60 BTL
ATC code N07XX N07XX
ATC description OTHER NERVOUS SYSTEM DRUGS OTHER NERVOUS SYSTEM DRUGS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-13 2020-01-13
Estimated end date 2021-12-14 2021-11-26
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments